<DOC>
	<DOCNO>NCT01781611</DOCNO>
	<brief_summary>Dipyridamole , medication extensively use combination aspirin stroke prevention , promise new treatment lupus . Dipyridamole show inhibit certain lymphocyte population over-reactive lupus delay emergence lupus-related pathology mouse lupus . The investigator interested investigate efficacy dipyridamole preventing flare patient lupus impact biomarkers disease activity .</brief_summary>
	<brief_title>Dipyridamole Assessment Flare Reduction Systemic Lupus Erythematosus ( SLE )</brief_title>
	<detailed_description>T cell systemic lupus erythematosus ( SLE ) express abnormal phenotype characterize increased effector function deficient regulatory response . Dipyridamole , phosphodiesterase inhibitor extensively use combination low dose aspirin secondary stroke prevention , propose specific T cell direct treatment SLE . Dipyridamole inhibit calcium/calcineurin/NF-AT pathway SLE T cell vitro abrogate expression cytokine costimulatory molecule , eventually also affect B cell response . Dipyridamole delay emergence lupus related pathology lupus prone mouse , yet study human SLE . The investigator aim investigate efficacy dipyridamole prevention flare SLE patient withdrawal background immunosuppressive medication . The investigator additionally evaluate safety tolerability dipyridamole impact quality life measure population . Furthermore , effect dipyridamole T B cell biomarkers examine .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<criteria>Patients SLE meeting 1997 ACR Classification Criteria Evidence positive ANA antidsDNA within one year screen SLEDAI ≥4 ≥1 BILAG A B screening , despite standard care Leukopenia ( WBC &lt; 2.000/mm3 ) lymhopenia ( lymphocytes &lt; 300/mm3 ) AST ALT &gt; 3 time normal cut value Acute lupus nephritis define class II , IV V nephritis diagnose within 6 month prot/creat &gt; 1.5 gm/gm due active lupus process receive induction therapy nephritis Active CNS lupus affect mental status Pregnancy breast feed Current requirement anticoagulation Contraindication aspirin dipyridamole , include history recent severe GI bleeding , hemoglobin &lt; 9 mg/dL , platelet count &lt; 30,000 /mm3 unstable platelet count Any medical condition , whether related lupus , opinion investigator would render patient inappropriate unstable complete study protocol Inability unwillingness understand and/or sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>lupus</keyword>
	<keyword>dipyridamole</keyword>
</DOC>